Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals     Drug formulations     ATC     Antiinfectives for Systemic Use     Vaccines     Animal Vaccines     Inactivated vaccines    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

North American Inactivated vaccines Market Research Report

  • Report Code: IN 1000
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The North American inactivated animal vaccine market, mainly driven by the growing prevalence of animal diseases and the increasing incidences of zoonotic diseases in humans, was valued at $627 million in 2013, and is projected to reach $818 million by 2018, at a CAGR of 5.5% during the period 2013 to 2018.

 

The market report analyzes the market in terms of 6 products, namely, aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The major types of this market include preventive and therapeutic. All these products are expected to experience a positive growth till 2018. Some important examples of inactivated vaccines are Nobivac rabies vaccine, Biomune Avian Polyomavirus Vaccine, Nobilis COR4+IB+ND+EDS, Nobilis Corvac, and Nobilis Coryza.

North America accounts for the second largest share in the global market. The rise in companion & farm animal and an increase in investments by companies helped to boost the market in the region. Moreover, preventive care will remain a driving factor in sales of animal health products as owners of commercial and companion animals alike recognize the need to maintain good health conditions for their animals. Continuous R&D investments by the leading market players for the development of new, innovative, and more-effective vaccines have also helped to boost the animal vaccines market in the region.

The report also provides an extensive competitive landscaping of the leading companies operating in this market. The main companies include Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac. Furthermore, the segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.

 

Customization Options

Along with the market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a deep-dive analysis of the following parameters:

 

Product Analysis:

  • Usage pattern (in-depth trend analysis) of products (segment-wise)
  • Product matrix, which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
  • End-user adoption rate analysis of the products (segment and country-wise)
  • A comprehensive coverage of product approvals, pipeline products, and product recalls

 

Epidemiology Data:

  • Country-specific prevalence of infectious Coryza, infectious bronchitis, Gumboro disease, Newcastle disease, foot & mouth diseases
  •  Country-specific patient infectious Coryza, infectious Bronchitis, Gumboro disease, Newcastle disease, foot & mouth diseases
  • Disease progression (pattern analysis)

 

Surgeons/Physicians Perception Matrix:

  • Fast turn-around analysis of surgeons’ responses to market events and trends
  • Pattern analysis of usage of inactivated vaccines by physicians
  • Surgeons’ opinions about products from different companies
  • Surgeons’ qualitative inputs on epidemiology data

 

Brand/Product Perception Matrix:

  • A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
  • An analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)

Competitive Intelligence:

  • The company share analysis of the top players of the market in the region
  • The crucial developments and strategies that companies inculcate in their portfolio

 

Alternative Products: Impact analysis

MMM’s Healthcare Decision Making Quadrant: It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters such as patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and clinics, diagnosis rate, treatment rate and healthcare expenditure)



1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 Inactivated vaccines-North America, By Types
4.1 Split By Geography
4.1 Inactivated vaccines-Canada by Types
4.1 Inactivated vaccines-U.S. by Types
4.1 Inactivated vaccines-Mexico by Types
4.2 Inactivated vaccines-Preventive-North America
4.2.1 Inactivated vaccines-Preventive-North America, By Products
4.2.1.1 Inactivated vaccines-Preventive-North America-Livestock
4.2.1.2 Inactivated vaccines-Preventive-North America-Porcine
4.2.1.3 Inactivated vaccines-Preventive-North America-Poultry
4.2.1.4 Inactivated vaccines-Preventive-North America-Companion animal vaccines
4.2.1.5 Inactivated vaccines-Preventive-North America-Equine
4.2.1.6 Inactivated vaccines-Preventive-North America-Aquaculture
4.2.2 Inactivated vaccines-Preventive-North America, By Geographies
4.2.2.1 Inactivated vaccines-Preventive-U.S.
4.2.2.2 Inactivated vaccines-Preventive-Canada
4.2.2.3 Inactivated vaccines-Preventive-Mexico
4.3 Inactivated vaccines-Therapeutic-North America
4.3.1 Inactivated vaccines-Therapeutic-North America, By Products
4.3.1.1 Inactivated vaccines-Therapeutic-North America-Livestock
4.3.1.2 Inactivated vaccines-Therapeutic-North America-Porcine
4.3.1.3 Inactivated vaccines-Therapeutic-North America-Poultry
4.3.1.4 Inactivated vaccines-Therapeutic-North America-Companion animal vaccines
4.3.1.5 Inactivated vaccines-Therapeutic-North America-Equine
4.3.1.6 Inactivated vaccines-Therapeutic-North America-Aquaculture
4.3.2 Inactivated vaccines-Therapeutic-North America, By Geographies
4.3.2.1 Inactivated vaccines-Therapeutic-U.S.
4.3.2.2 Inactivated vaccines-Therapeutic-Canada
4.3.2.3 Inactivated vaccines-Therapeutic-Mexico
5 Inactivated vaccines-North America, By Products
5.1 Split By Geography
5.2 Inactivated vaccines-Canada by Products
5.1 Inactivated vaccines-U.S. by Products
5.1 Inactivated vaccines-Mexico by Products
5.2 Inactivated vaccines-North America-Livestock
5.2.1 Inactivated vaccines-North America-Livestock, By Types
5.2.1.1 Inactivated vaccines-Preventive-North America-Livestock
5.2.1.2 Inactivated vaccines-Therapeutic-North America-Livestock
5.2.2 Inactivated vaccines-North America-Livestock, By Geographies
5.2.2.1 Inactivated vaccines-U.S.-Livestock
5.2.2.2 Inactivated vaccines-Canada-Livestock
5.3 Inactivated vaccines-North America-Porcine
5.3.1 Inactivated vaccines-North America-Porcine, By Types
5.3.1.1 Inactivated vaccines-Preventive-North America-Porcine
5.3.1.2 Inactivated vaccines-Therapeutic-North America-Porcine
5.3.2 Inactivated vaccines-North America-Porcine, By Geographies
5.3.2.1 Inactivated vaccines-U.S.-Porcine
5.3.2.2 Inactivated vaccines-Canada-Porcine
5.4 Inactivated vaccines-North America-Poultry
5.4.1 Inactivated vaccines-North America-Poultry, By Types
5.4.1.1 Inactivated vaccines-Preventive-North America-Poultry
5.4.1.2 Inactivated vaccines-Therapeutic-North America-Poultry
5.4.2 Inactivated vaccines-North America-Poultry, By Geographies
5.4.2.1 Inactivated vaccines-U.S.-Poultry
5.4.2.2 Inactivated vaccines-Canada-Poultry
5.5 Inactivated vaccines-North America-Companion animal vaccines
5.5.1 Inactivated vaccines-North America-Companion animal vaccines, By Types
5.5.1.1 Inactivated vaccines-Preventive-North America-Companion animal vaccines
5.5.1.2 Inactivated vaccines-Therapeutic-North America-Companion animal vaccines
5.5.2 Inactivated vaccines-North America-Companion animal vaccines, By Geographies
5.5.2.1 Inactivated vaccines-U.S.-Companion animal vaccines
5.5.2.2 Inactivated vaccines-Canada-Companion animal vaccines
5.6 Inactivated vaccines-North America-Equine
5.6.1 Inactivated vaccines-North America-Equine, By Types
5.6.1.1 Inactivated vaccines-Preventive-North America-Equine
5.6.1.2 Inactivated vaccines-Therapeutic-North America-Equine
5.6.2 Inactivated vaccines-North America-Equine, By Geographies
5.6.2.1 Inactivated vaccines-U.S.-Equine
5.6.2.2 Inactivated vaccines-Canada-Equine
5.7 Inactivated vaccines-North America-Aquaculture
5.7.1 Inactivated vaccines-North America-Aquaculture, By Types
5.7.1.1 Inactivated vaccines-Preventive-North America-Aquaculture
5.7.1.2 Inactivated vaccines-Therapeutic-North America-Aquaculture
5.7.2 Inactivated vaccines-North America-Aquaculture, By Geographies
5.7.2.1 Inactivated vaccines-U.S.-Aquaculture
5.7.2.2 Inactivated vaccines-Canada-Aquaculture
6 Inactivated vaccines-North America, By Geographies
6.1 Inactivated vaccines-Canada
6.1.1 Inactivated vaccines-Canada, By Types
6.1.1.1 Inactivated vaccines-Preventive-Canada
6.1.1.2 Inactivated vaccines-Therapeutic-Canada
6.1.2 Inactivated vaccines-Canada, By Products
6.1.2.1 Inactivated vaccines-Canada-Livestock
6.1.2.2 Inactivated vaccines-Canada-Porcine
6.1.2.3 Inactivated vaccines-Canada-Poultry
6.1.2.4 Inactivated vaccines-Canada-Companion animal vaccines
6.1.2.5 Inactivated vaccines-Canada-Equine
6.1.2.6 Inactivated vaccines-Canada-Aquaculture
6.2 Inactivated vaccines-U.S.
6.2.1 Inactivated vaccines-U.S., By Types
6.2.1.1 Inactivated vaccines-Preventive-U.S.
6.2.1.2 Inactivated vaccines-Therapeutic-U.S.
6.2.2 Inactivated vaccines-U.S., By Products
6.2.2.1 Inactivated vaccines-U.S.-Livestock
6.2.2.2 Inactivated vaccines-U.S.-Porcine
6.2.2.3 Inactivated vaccines-U.S.-Poultry
6.2.2.4 Inactivated vaccines-U.S.-Companion animal vaccines
6.2.2.5 Inactivated vaccines-U.S.-Equine
6.2.2.6 Inactivated vaccines-U.S.-Aquaculture
6.3 Inactivated vaccines-Mexico
6.3.1 Inactivated vaccines-Mexico, By Types
6.3.1.1 Inactivated vaccines-Preventive-Mexico
6.3.1.2 Inactivated vaccines-Therapeutic-Mexico

Please fill in the form below to receive a free copy of the Summary of this Report
















North American Inactivated vaccines Market Research Report

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Connect With Us
US/CAN : +1-888-502-0539